Benjamin D Lovin1, Mike Hernandez2, Hunter Elms3, Jonathan S Choi1, Nathan R Lindquist1, Amy C Moreno4, Marc-Elie Nader5, Paul W Gidley5. 1. Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, U.S.A. 2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A. 3. Department of Otolaryngology-Head and Neck Surgery, Duke University, Durham, North Carolina, U.S.A. 4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A. 5. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: To report the largest single-institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. STUDY DESIGN: Retrospective chart review. METHODS: Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. RESULTS: TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow-up. On multivariable analysis, diabetes, three-dimensional conformal radiotherapy (3D-CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. CONCLUSIONS: TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D-CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:2578-2585, 2021.
OBJECTIVES/HYPOTHESIS: To report the largest single-institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. STUDY DESIGN: Retrospective chart review. METHODS: Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. RESULTS: TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow-up. On multivariable analysis, diabetes, three-dimensional conformal radiotherapy (3D-CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. CONCLUSIONS: TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D-CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:2578-2585, 2021.
Authors: Quinten Kammeijer; Erik van Spronsen; Piet G B Mirck; Wouter A Dreschler Journal: Otolaryngol Head Neck Surg Date: 2015-01-05 Impact factor: 3.497
Authors: Benjamin D Lovin; Jonathan S Choi; Nathan R Lindquist; Jack Phan; Paul W Gidley; Marc-Elie Nader Journal: Otol Neurotol Date: 2020-12 Impact factor: 2.311
Authors: Salmaan Ahmed; Nakul Gupta; Jackson D Hamilton; Adam S Garden; Paul W Gidley; Lawrence E Ginsberg Journal: J Comput Assist Tomogr Date: 2014 Sep-Oct Impact factor: 1.826
Authors: Mark C Korpics; W Tyler Turchan; Michael K Rooney; Matthew Koshy; Michael T Spiotto Journal: Cancers (Basel) Date: 2019-12-12 Impact factor: 6.639
Authors: Gabriela Studer; Marius Bredell; Stephan Studer; Gerhard Huber; Christoph Glanzmann Journal: Strahlenther Onkol Date: 2015-08-12 Impact factor: 3.621